{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:15:03Z","timestamp":1786994103282,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.mehy.2019.02.035","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T03:09:37Z","timestamp":1550113777000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Tea polyphenols as multi-target therapeutics for Alzheimer\u2019s disease: An in silico study"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-1164","authenticated-orcid":false,"given":"Muhammed Khairujjaman","family":"Mazumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2051-4546","authenticated-orcid":false,"given":"Shuvasish","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2019.02.035_b0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model","volume":"288","author":"Avrahami","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2019.02.035_b0010","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11182","article-title":"Sampling the conformational space of the catalytic subunit of human \u03b3-secretase","volume":"4","author":"Bai","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.mehy.2019.02.035_b0015","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2019.02.035_b0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2005.01.031","article-title":"Cognitive correlates of alterations in acetylcholinesterase in Alzheimer\u2019s disease","volume":"380","author":"Bohnen","year":"2005","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.mehy.2019.02.035_b0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-011-0825-z","article-title":"Alzheimer\u2019s pathogenesis: is there neuron-to-neuron propagation?","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.mehy.2019.02.035_b0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0955-2863(02)00205-X","article-title":"Nutritional approaches to combat oxidative stress in Alzheimer\u2019s disease","volume":"13","author":"Butterfield","year":"2002","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.mehy.2019.02.035_b0035","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.mehy.2019.02.035_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/428010","article-title":"Mechanism of oxidative stress in neurodegeneration","volume":"2012","author":"Gandhi","year":"2012","journal-title":"Oxid Med Cell Longevity"},{"key":"10.1016\/j.mehy.2019.02.035_b0045","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2174\/0929867023370149","article-title":"\u03b2-Secretase as a therapeutic target for inhibitor drugs","volume":"9","author":"Ghosh","year":"2002","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.mehy.2019.02.035_b0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer\u2019s disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.mehy.2019.02.035_b0055","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2019.02.035_b0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408690390826464","article-title":"Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions","volume":"43","author":"Higdon","year":"2003","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.mehy.2019.02.035_b0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.290.5489.150","article-title":"Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor","volume":"290","author":"Hong","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.mehy.2019.02.035_b0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuint.2018.08.001","article-title":"Phenylpropanoids and Alzheimer\u2019s disease: a potential therapeutic platform","volume":"120","author":"Kolaj","year":"2018","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mehy.2019.02.035_b0075","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mehy.2019.02.035_b0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00044-015-1472-z","article-title":"Garcinol prevents hyperhomocysteinemia and enhances bioavailability of L-DOPA by inhibiting catechol-o-methyltransferase: an in silico approach","volume":"25","author":"Mazumder","year":"2015","journal-title":"Med Chem Res"},{"key":"10.1016\/j.mehy.2019.02.035_b0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.mehy.2014.09.021","article-title":"Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis","volume":"83","author":"Mazumder","year":"2014","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.mehy.2019.02.035_b0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.6026\/97320630011217","article-title":"Piroxicam confer neuroprotection in Cerebral Ischemia by inhibiting cyclooxygenases, acid-sensing ion channel-1a and aquaporin-4: an in silico elucidation of a novel mechanism","volume":"11","author":"Mazumder","year":"2015","journal-title":"Bioinformation"},{"key":"10.1016\/j.mehy.2019.02.035_b0095","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.mehy.2014.09.031","article-title":"Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug","volume":"83","author":"Mazumder","year":"2014","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.mehy.2019.02.035_b0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/cns.12113","article-title":"\u03b2-phenethylamine \u2013 a phenylalanine derivate in brain \u2013 contributes to oxidative stress by inhibiting mitochondrial complexes and DT-diaphorase: an in silico study","volume":"19","author":"Mazumder","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.mehy.2019.02.035_b0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mehy.2018.06.009","article-title":"Garcinol, an effective monoamine oxidase-B inhibitor for the treatment of Parkinson\u2019s disease","volume":"117","author":"Mazumder","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.02.035_b0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mehy.2017.12.016","article-title":"Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment","volume":"111","author":"Mazumder","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.02.035_b0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20130013","article-title":"Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl- and butyrylcholinesterase","volume":"453","author":"Nachon","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.mehy.2019.02.035_b0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","article-title":"Amyloid beta peptides and glutamatergic synaptic dysregulation","volume":"210","author":"Parameshwaran","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.mehy.2019.02.035_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-2236(98)01361-7","article-title":"Acetylcholine in mind: a neurotransmitter correlate of consciousness?","volume":"22","author":"Perry","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2019.02.035_b0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterase in senile dementia of Alzheimer\u2019s type","volume":"4","author":"Perry","year":"1978","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.mehy.2019.02.035_b0135","unstructured":"Prince MWA, Guerchet M, Ali G, Wu Y, Prina M. The global impact of Dementia: An analysis of prevalence, Incidence, Costs and trends. Alzheimer\u2019s Disease Int. https:\/\/www.alz.co.uk\/research\/WorldAlzheimerReport2015.pdf."},{"key":"10.1016\/j.mehy.2019.02.035_b0140","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.mehy.2019.02.035_b0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular pathogenesis of Alzheimer\u2019s disease: an update","volume":"24","author":"Sanabria-Castro","year":"2017","journal-title":"Ann Neurosci"},{"key":"10.1016\/j.mehy.2019.02.035_b0150","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.mehy.2019.02.035_b0155","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/cb400080f","article-title":"Untangling amyloid-\u03b2, tau, and metals in Alzheimer\u2019s disease","volume":"8","author":"Savelieff","year":"2013","journal-title":"ACS Chem Biol"},{"issue":"10043","key":"10.1016\/j.mehy.2019.02.035_b0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2019.02.035_b0165","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.mehy.2019.02.035_b0170","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","article-title":"The importance of neuritic plaques and tangles to the development and evolution of AD","volume":"62","author":"Tiraboschi","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mehy.2019.02.035_b0175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","article-title":"The role of inflammation in Alzheimer\u2019s disease","volume":"37","author":"Tuppo","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.mehy.2019.02.035_b0180","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.devcel.2015.01.022","article-title":"Cellular functions of the amyloid precursor protein from development to dementia","volume":"32","author":"van der Kant","year":"2015","journal-title":"Dev Cell"},{"key":"10.1016\/j.mehy.2019.02.035_b0185","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"\u03b2-Secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.mehy.2019.02.035_b0190","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jnutbio.2004.05.002","article-title":"Neurological mechanisms of green tea polyphenols in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"15","author":"Weinreb","year":"2004","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.mehy.2019.02.035_b0195","first-page":"7","article-title":"Neuropathologic changes in Alzheimer's disease","volume":"64","author":"Wenk","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2019.02.035_b0200","first-page":"529","article-title":"Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease","volume":"88","author":"Wischik","year":"2014","journal-title":"Biomed Pharmacol"},{"issue":"2014","key":"10.1016\/j.mehy.2019.02.035_b9000","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.jalz.2014.02.001","article-title":"Alzheimer's disease facts and figures","volume":"10","author":"Association","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.mehy.2019.02.035_b9005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2019.02.035_b9010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1471-4159.2003.01976.x","article-title":"Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease","volume":"87","author":"Ono","year":"2003","journal-title":"J Neurochem"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718313392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718313392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T14:11:01Z","timestamp":1606486261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718313392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"alternative-id":["S0306987718313392"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.02.035","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tea polyphenols as multi-target therapeutics for Alzheimer\u2019s disease: An in silico study","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}